Want to see AU:SHG full AI Analyst Report?
Top Page
Singular Health Group Ltd
(Sydney:SHG)
Select Model
Select Model
Rating:44Neutral
Price Target:
AU$0.18
▼(-32.69% Downside)
Action:Reiterated
Date:09/06/26
The score is held down primarily by sustained losses and ongoing cash burn (negative margins, negative operating cash flow/free cash flow), despite improved revenue momentum and a less leveraged balance sheet. Technicals add additional pressure with the stock trading below key moving averages and a negative MACD, while valuation remains challenging due to losses implied by the negative P/E.
Positive Factors
Improved balance sheet (zero debt)
The reported zero debt position and a large equity base in 2025 materially reduce near-term refinancing and interest-rate risk. That balance sheet flexibility supports operational continuity and gives management time to execute strategy or seek non-debt funding without immediate liquidity pressure.
Negative Factors
Persistent losses and very negative margins
Sustained multi-year losses and extremely negative margins indicate the business has not reached a viable profitability model. Over months, this undermines internal reinvestment capacity, heightens dependence on external capital, and makes durable margin improvement a prerequisite for long-term viability.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved balance sheet (zero debt)
The reported zero debt position and a large equity base in 2025 materially reduce near-term refinancing and interest-rate risk. That balance sheet flexibility supports operational continuity and gives management time to execute strategy or seek non-debt funding without immediate liquidity pressure.
Read all positive factors
Singular Health Group Ltd (SHG) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$58.70M
Dividend YieldN/A
Average Volume (3M)261.05K
Price to Earnings (P/E)―
Beta (1Y)0.93
Revenue Growth603.32%
EPS Growth10.57%
CountryAU
Employees8
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.02
Shares Outstanding326,091,300
10 Day Avg. Volume242,035
30 Day Avg. Volume261,046
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)6.53
Price to Sales (P/S)48.14
P/FCF Ratio-12.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Singular Health Group Ltd Business Overview & Revenue Model
Company Description
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of a...
How the Company Makes Money
null...
Singular Health Group Ltd Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
22
Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.43M | 557.61K | 934.07K | 28.12K | 54.03K |
| Gross Profit | -4.02M | -86.22K | 516.36K | -3.58M | -2.11M |
| EBITDA | -6.69M | -6.27M | -2.58M | -4.52M | -5.65M |
| Net Income | -6.34M | -6.38M | -4.92M | -5.39M | -5.99M |
Balance Sheet | |||||
| Total Assets | 11.24M | 14.21M | 2.35M | 3.00M | 2.14M |
| Cash, Cash Equivalents and Short-Term Investments | 10.06M | 13.68M | 1.45M | 691.51K | 1.14M |
| Total Debt | 109.96K | 0.00 | 218.45K | 2.51M | 85.66K |
| Total Liabilities | 699.20K | 1.11M | 909.59K | 2.94M | 391.50K |
| Stockholders Equity | 10.54M | 13.10M | 1.44M | 61.89K | 1.75M |
Cash Flow | |||||
| Free Cash Flow | -5.45M | -2.37M | -2.51M | -2.49M | -2.92M |
| Operating Cash Flow | -5.30M | -2.34M | -2.44M | -2.46M | -2.91M |
| Investing Cash Flow | 5.37M | 88.14K | -3.56K | -635.21K | -17.12K |
| Financing Cash Flow | 1.67M | 14.48M | 3.21M | 2.65M | -69.25K |
Singular Health Group Ltd Technical Analysis
Negative
0.26
Price Trends
0.20
Negative
0.20
Negative
0.22
Negative
Market Momentum
>-0.01
Negative
43.64
Neutral
44.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SHG, the sentiment is Negative. The current price of 0.26 is above the 20-day moving average (MA) of 0.18, above the 50-day MA of 0.20, and above the 200-day MA of 0.22, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.64 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SHG.
Singular Health Group Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | AU$27.67M | 18.13 | 13.72% | ― | 42.25% | ― | |
61 Neutral | AU$141.73M | 61.76 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | AU$35.44M | -1.91 | -58.13% | ― | 2.08% | -195.31% | |
47 Neutral | AU$65.80M | -7.37 | -24.29% | ― | -17.35% | -47.29% | |
47 Neutral | AU$682.85M | -24.02 | -30.04% | ― | <0.01% | 2.08% | |
44 Neutral | AU$58.70M | -8.87 | -57.06% | ― | 603.32% | 10.57% |
* Healthcare Sector Average
AU:SHG
Singular Health Group Ltd
0.18
-0.12
-40.00%
AU:M7T
Mach7 Technologies
0.28
-0.03
-11.11%
AU:RHT
Resonance Health Ltd
0.06
0.02
65.71%
AU:BMT
Beamtree Holdings Ltd
0.12
-0.11
-47.83%
AU:AYA
Artrya Limited
4.18
2.00
91.74%
AU:ALC
Alcidion Group Limited
0.11
0.02
16.67%
Singular Health Group Ltd Corporate Events
Singular Health Lodges ASX Corporate Governance Statement and Appendix 4G
Aug 30, 2026
Singular Health Group Ltd, an ASX-listed entity, has detailed its governance framework for the year ended 30 June 2026, including a board charter, appointment processes for directors and senior executives, and the company secretary’s direct ...
Singular Health boosts revenue and expands globally despite ongoing losses
Aug 30, 2026
Singular Health Group Limited reported a sharp increase in revenues from ordinary activities to $1.43 million for the year ended 30 June 2026, up 507% from the prior year, while its loss after tax narrowed slightly to $6.34 million. Net tangible a...
Singular Health Group Seeks ASX Quotation for 1.8 Million New Shares
Aug 17, 2026
Singular Health Group Ltd has applied for quotation on the ASX of 1,818,182 ordinary fully paid shares, with an issue date of 17 August 2026. The new share quotation expands the company’s listed equity base, potentially enhancing liquidity f...
Singular Health builds U.S. imaging footprint with PNS expansion, Florida pilots and Miami-Dade rollout
Jul 31, 2026
Singular Health Group reported a quarter of commercial and operational momentum, highlighting deeper engagement with U.S. healthcare payers and education providers as it builds out scalable imaging infrastructure solutions. The company ended the J...
Singular Health to Release 1 Million Shares from Voluntary Escrow
Jul 1, 2026
Singular Health Group Ltd has announced that 1,000,000 fully paid ordinary shares will be released from voluntary escrow on 25 July 2026, while confirming that this move will not alter the company’s issued capital. The release, authorised by...
Singular Health Options Expire, Simplifying Capital Structure
Jul 1, 2026
Singular Health Group Ltd has confirmed the expiry of a series of listed options, SHGAAB, which were exercisable at $0.10 and expired on 26 June 2026, resulting in the cessation of 3,233,441 securities. The announcement clarifies that these option...
Singular Health Raises Capital via Option Exercise and Issues Cleansing Notice
Jun 28, 2026
Singular Health Group has strengthened its capital base by issuing 2,571,222 fully paid ordinary shares following the exercise of an equal number of unlisted options at $0.10 each, raising $257,122.20. The company has applied to quote the new shar...
Singular Health Seeks Quotation for Additional ASX Shares
Jun 28, 2026
Singular Health Group Ltd has applied for the quotation of 2,571,222 new ordinary fully paid shares on the Australian Securities Exchange. The securities, issued on 26 June 2026, arise from the exercise of options or conversion of other securities...
Singular Health Director Increases Stake Through Option Exercise
Jun 24, 2026
Singular Health Group has disclosed a change in director Denning Chong’s interests following the exercise of unlisted options held through an associated entity. The transaction converted 1,818,182 unlisted options priced at $0.10 into the sa...
Singular Health Raises Capital via Option Exercises and Issues Cleansing Notice
Jun 22, 2026
Singular Health Group has raised a total of $432,272.70 through the exercise of unlisted options, issuing 4,460,227 new fully paid ordinary shares at strike prices of $0.10 and $0.08. The company has applied to have these shares quoted on the ASX ...
Singular Health Seeks Quotation of 4.46 Million New ASX Shares
Jun 22, 2026
Singular Health Group Ltd, an ASX-listed health technology company trading under ticker SHG, develops digital healthcare and medical imaging solutions for clinical and allied health users. The company targets technology-enabled healthcare workflow...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.